Wnt/β-catenin signaling in adipogenesis and metabolism

Current Opinion in Cell Biology

Volumn 19, Issue 6, 2007, Pages 612-617

  Prestwich, Tyler C ^a   MacDougald, Ormond A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL FATE; FIBROBLAST; HUMAN; MESENCHYME CELL; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; HUMANS; SIGNAL TRANSDUCTION; WNT PROTEINS;

ANIMALIA;

EID: 36849010732     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2007.09.014     Document Type: Review

References (54)

1. Rosen E.D., Walkey C.J., Puigserver P., and Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev 14 (2000) 1293-1307
2. Farmer S.R. Transcriptional control of adipocyte formation. Cell Metab 4 (2006) 263-273
3. Rosen E.D., and MacDougald O.A. Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7 (2006) 885-896
4. Wu Z., Rosen E.D., Brun R., Hauser S., Adelmant G., Troy A.E., McKeon C., Darlington G.J., and Spiegelman B.M. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol Cell 3 (1999) 151-158
5. Logan C.Y., and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20 (2004) 781-810
6. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 127 (2006) 469-480
7. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., and MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
8. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., Harrison S.D., and MacDougald O.A. Regulation of Wnt signaling during adipogenesis. J Biol Chem 277 (2002) 30998-31004
9. Longo K.A., Wright W.S., Kang S., Gerin I., Chiang S.H., Lucas P.C., Opp M.R., and MacDougald O.A. Wnt10b inhibits development of white and brown adipose tissues. J Biol Chem 279 (2004) 35503-35509
10. Wright W.S., Longo K.A., Dolinsky V.W., Gerin I., Kang S., Bennett C.N., Chiang S.H., Prestwich T.C., Gress C., Burant C.F., et al. Wnt10b inhibits obesity in ob/ob and agouti mice. Diabetes 56 (2007) 295-303. Study showing that mice expressing Wnt10b from the FABP4 promoter resist expansion of adipose tissue associated with genetic obesity, providing compelling evidence that Wnt10b is an important factor regulating adipogenesis in vivo.
11. Moldes M., Zuo Y., Morrison R.F., Silva D., Park B.H., Liu J., and Farmer S.R. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. Biochem J 376 (2003) 607-613
12. Kennell J.A., and MacDougald O.A. Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J Biol Chem 280 (2005) 24004-24010
13. Arango N.A., Szotek P.P., Manganaro T.F., Oliva E., Donahoe P.K., and Teixeira J. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 288 (2005) 276-283. This is the first study to present molecular evidence suggesting that the Wnt/β-catenin pathway is an important regulator of mesenchymal cell fate in vivo. The authors observed a conversion of myometrial smooth muscle to adipose tissue in conditional β-catenin knockout mice.
14. Li F.Q., Singh A.M., Mofunanya A., Love D., Terada N., Moon R.T., and Takemaru K. Chibby promotes adipocyte differentiation through inhibition of beta-catenin signaling. Mol Cell Biol 27 (2007) 4347-4354
15. Waki H., Park K.W., Mitro N., Pei L., Damoiseaux R., Wilpitz D.C., Reue K., Saez E., and Tontonoz P. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression. Cell Metab 5 (2007) 357-370
16. Christodoulides C., Laudes M., Cawthorn W.P., Schinner S., Soos M., O'Rahilly S., Sethi J.K., and Vidal-Puig A. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J Cell Sci 119 (2006) 2613-2620
17. Tseng Y.H., Kriauciunas K.M., Kokkotou E., and Kahn C.R. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol Cell Biol 24 (2004) 1918-1929
18. Tseng Y.H., Butte A.J., Kokkotou E., Yechoor V.K., Taniguchi C.M., Kriauciunas K.M., Cypess A.M., Niinobe M., Yoshikawa K., Patti M.E., et al. Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol 7 (2005) 601-611
19. Kanazawa A., Tsukada S., Sekine A., Tsunoda T., Takahashi A., Kashiwagi A., Tanaka Y., Babazono T., Matsuda M., Kaku K., et al. Association of the gene encoding wingless-type mammary tumor virus integration-site family member 5B (WNT5B) with type 2 diabetes. Am J Hum Genet 75 (2004) 832-843
20. Kanazawa A., Tsukada S., Kamiyama M., Yanagimoto T., Nakajima M., and Maeda S. Wnt5b partially inhibits canonical Wnt/beta-catenin signaling pathway and promotes adipogenesis in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 330 (2005) 505-510
21. Ross S.E., Erickson R.L., Gerin I., DeRose P.M., Bajnok L., Longo K.A., Misek D.E., Kuick R., Hanash S.M., Atkins K.B., et al. Microarray analyses during adipogenesis: understanding the effects of Wnt signaling on adipogenesis and the roles of liver X receptor alpha in adipocyte metabolism. Mol Cell Biol 22 (2002) 5989-5999
22. Takemaru K., Yamaguchi S., Lee Y.S., Zhang Y., Carthew R.W., and Moon R.T. Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway. Nature 422 (2003) 905-909
23. Kang S., Bajnok L., Longo K.A., Petersen R.K., Hansen J.B., Kristiansen K., and MacDougald O.A. Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha. Mol Cell Biol 25 (2005) 1272-1282
24. Gesta S., Bluher M., Yamamoto Y., Norris A.W., Berndt J., Kralisch S., Boucher J., Lewis C., and Kahn C.R. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A 103 (2006) 6676-6681
25. Koza R.A., Nikonova L., Hogan J., Rim J.S., Mendoza T., Faulk C., Skaf J., and Kozak L.P. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet 2 (2006) e81
26. Bodine P.V., Zhao W., Kharode Y.P., Bex F.J., Lambert A.J., Goad M.B., Gaur T., Stein G.S., Lian J.B., and Komm B.S. The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice. Mol Endocrinol 18 (2004) 1222-1237
27. Kumar S., Leontovich A., Coenen M.J., and Bahn R.S. Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis. J Clin Endocrinol Metab 90 (2005) 4730-4735
28. Lee J.L., Lin C.T., Chueh L.L., and Chang C.J. Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: a possible mechanism of mammary tumorigenesis. J Biol Chem 279 (2004) 14602-14609
29. Rodriguez J., Esteve P., Weinl C., Ruiz J.M., Fermin Y., Trousse F., Dwivedy A., Holt C., and Bovolenta P. SFRP1 regulates the growth of retinal ganglion cell axons through the Fz2 receptor. Nat Neurosci 8 (2005) 1301-1309
30. Lee H.X., Ambrosio A.L., Reversade B., and De Robertis E.M. Embryonic dorsal-ventral signaling: secreted frizzled-related proteins as inhibitors of tolloid proteinases. Cell 124 (2006) 147-159
31. Christodoulides C., Scarda A., Granzotto M., Milan G., Dalla Nora E., Keogh J., De Pergola G., Stirling H., Pannacciulli N., Sethi J.K., et al. WNT10B mutations in human obesity. Diabetologia 49 (2006) 678-684
32. Guo Y.F., Xiong D.H., Shen H., Zhao L.J., Xiao P., Guo Y., Wang W., Yang T.L., Recker R.R., and Deng H.W. Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 43 (2006) 798-803
33. Mani A., Radhakrishnan J., Wang H., Mani A., Mani M.A., Nelson-Williams C., Carew K.S., Mane S., Najmabadi H., Wu D., et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315 (2007) 1278-1282
34. Grant S.F., Thorleifsson G., Reynisdottir I., Benediktsson R., Manolescu A., Sainz J., Helgason A., Stefansson H., Emilsson V., Helgadottir A., et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38 (2006) 320-323. This is the first of many studies linking variants in the TCF7L2 gene to type 2 diabetes. Numerous reports have since come out confirming and extending this finding in various populations around the world.
35. Groves C.J., Zeggini E., Minton J., Frayling T.M., Weedon M.N., Rayner N.W., Hitman G.A., Walker M., Wiltshire S., Hattersley A.T., et al. Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 55 (2006) 2640-2644
36. Scott L.J., Bonnycastle L.L., Willer C.J., Sprau A.G., Jackson A.U., Narisu N., Duren W.L., Chines P.S., Stringham H.M., Erdos M.R., et al. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes 55 (2006) 2649-2653
37. Cauchi S., Meyre D., Dina C., Choquet H., Samson C., Gallina S., Balkau B., Charpentier G., Pattou F., Stetsyuk V., et al. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes. Diabetes 55 (2006) 2903-2908
38. Mayans S., Lackovic K., Lindgren P., Ruikka K., Agren A., Eliasson M., and Holmberg D. TCF7L2 polymorphisms are associated with type 2 diabetes in northern Sweden. Eur J Hum Genet 15 (2007) 342-346
39. Zhang C., Qi L., Hunter D.J., Meigs J.B., Manson J.E., van Dam R.M., and Hu F.B. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of U.S. women and men. Diabetes 55 (2006) 2645-2648
40. Damcott C.M., Pollin T.I., Reinhart L.J., Ott S.H., Shen H., Silver K.D., Mitchell B.D., and Shuldiner A.R. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55 (2006) 2654-2659
41. Lehman D.M., Hunt K.J., Leach R.J., Hamlington J., Arya R., Abboud H.E., Duggirala R., Blangero J., Goring H.H., and Stern M.P. Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes 56 (2007) 389-393
42. Yi F., Brubaker P.L., and Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 280 (2005) 1457-1464
43. Saxena R., Gianniny L., Burtt N.P., Lyssenko V., Giuducci C., Sjogren M., Florez J.C., Almgren P., Isomaa B., Orho-Melander M., et al. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55 (2006) 2890-2895
44. Krishnan V., Bryant H.U., and Macdougald O.A. Regulation of bone mass by Wnt signaling. J Clin Invest 116 (2006) 1202-1209
45. Bennett C.N., Longo K.A., Wright W.S., Suva L.J., Lane T.F., Hankenson K.D., and MacDougald O.A. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A 102 (2005) 3324-3329. This was an important study indicating that Wnt/β-catenin signaling stimulates osteoblastogenesis and inhibits adipogenesis of bipotential mesenchymal precursors and that Wnt10b regulates bone formation in vivo.
46. Kang S., Bennett C.N., Gerin I., Rapp L.A., Hankenson K.D., and Macdougald O.A. Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. J Biol Chem 282 (2007) 14515-14524. Using bipotential ST2 cells, the authors showed that transient activation of Wnt/β-catenin signaling led to a rapid suppression of C/EBPα and PPARγ followed by an increase in osteoblastic transcription factors, suggesting that Wnt/β-catenin signaling alters mesenchymal cell fate primarily through suppression of C/EBPα and PPARγ.
47. Liu J., and Farmer S.R. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J Biol Chem 279 (2004) 45020-45027
48. Liu J., Wang H., Zuo Y., and Farmer S.R. Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Mol Cell Biol 26 (2006) 5827-5837. The authors of this study showed that PPARγ and β-catenin functionally interact to negatively regulate each other's activity, thus providing important insight into the mechanisms by which these two crucial factors regulate adipogenesis.
49. Taylor-Jones J.M., McGehee R.E., Rando T.A., Lecka-Czernik B., Lipschitz D.A., and Peterson C.A. Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 123 (2002) 649-661
50. Vertino A.M., Taylor-Jones J.M., Longo K.A., Bearden E.D., Lane T.F., McGehee Jr. R.E., MacDougald O.A., and Peterson C.A. Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell 16 (2005) 2039-2048
51. Cawthorn W.P., Heyd F., Hegyi K., and Sethi J.K. Tumour necrosis factor-alpha inhibits adipogenesis via a beta-catenin/TCF4(TCF7L2)-dependent pathway. Cell Death Differ 14 (2007) 1361-1373
52. Gustafson B., and Smith U. Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. J Biol Chem 281 (2006) 9507-9516
53. Singh R., Artaza J.N., Taylor W.E., Braga M., Yuan X., Gonzalez-Cadavid N.F., and Bhasin S. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147 (2006) 141-154
54. Cianferotti L., and Demay M.B. VDR-mediated inhibition of DKK1 and SFRP2 suppresses adipogenic differentiation of murine bone marrow stromal cells. J Cell Biochem 101 (2007) 80-88